Resources

Filter by

December 20, 2025
Blog

CY 2026 Medicare Final Rules: Your Pharma Compliance Checklist for PFS, OPPS, & ASC

Government Pricing

December 18, 2025
Blog

Pharma/Biotech CFO Industry Insights on Net Revenue Optimization

Gross-to-Net

September 17, 2025
Blog

Unpacking IPAY 2028: Part B Drugs, New Invoices, & the MFP

Government Pricing

September 10, 2025
Blog

Unifying Data for Commercialization of Pharmaceutical Products in the New Era

Government Pricing

July 17, 2025
Blog

How Pharma Manufacturers Can Navigate the 340B Program & Stay Up to Date

340B

July 8, 2025
Blog

State Price Transparency: How to Navigate Evolving Laws

Market Access

June 16, 2025
Blog

Unpacking Trump’s Drug Pricing Executive Order & the 2026 Part D Redesign

Market Access

June 4, 2025
Blog

Optimizing Pharma Net Revenue Under New Market Dynamics

Gross-to-Net

May 30, 2025
Blog

Bringing Clarity to the Complexities of Pharma Commercial Data at Asembia 2025

Channel

May 21, 2025
Blog

What MFN Pricing Initiatives Mean for Manufacturers: Key Insights from the Latest HHS Pharma Update

Market Access

April 24, 2025
Blog

Navigating Pharma Distribution Models: Insights from Industry Leaders, Part 2

Market Access

March 27, 2025
Blog

Direct-to-Patient & Fair Drug Pricing: Reshaping the Pharmacy Landscape

Market Access